サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1632602

止血バルブの世界市場：市場規模・シェア・動向分析 (種類別・用途別・最終用途別・地域別・セグメント別、2025年～2030年)

Hemostasis Valve Market Size, Share & Trends Analysis Report By Type (Hemostasis Valve Y- Connectors, Double Y- Connector Hemostasis Valves), By Application (Angiography, Angioplasty), By End Use, By Region and Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 130 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
止血バルブの世界市場：市場規模・シェア・動向分析 (種類別・用途別・最終用途別・地域別・セグメント別、2025年～2030年)
出版日: 2024年12月24日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

止血バルブの市場規模と動向：

世界の止血バルブの市場規模は2024年に1億8,460万米ドルと推計され、2025年から2030年にかけてCAGR 5.8％で成長すると予測されています。

心血管疾患の有病率の増加、支持的な規制の枠組み、高齢者人口の増加、技術の進歩が市場成長を大きく促進しています。World Heart Report 2024は、大気汚染がすべての主要な心血管疾患（CVD）を悪化させることを強調しています。2019年には、周囲の大気汚染に関連する420万人の死亡者のうち70％近くが心血管問題、特に虚血性心疾患（190万人死亡）と脳卒中（90万人死亡）によるものでした。このため、血管造影や血管形成術のような診断・治療手技の需要が高まっており、止血バルブはカテーテル治療中に血流を制御して患者の安全を確保するために不可欠です。

低侵襲手技への嗜好の高まりも市場成長を後押しする重要な要因です。低侵襲手技は、従来の開腹手術に比べて、痛みの軽減、入院期間の短縮、回復時間の短縮、合併症リスクの低下など、数多くの利点を提供します。その結果、これらの手技を容易にする医療機器に対する需要が高まっています。止血バルブは、血流の正確な制御を可能にし、手技中の漏れを防ぐため、低侵襲のカテーテルを用いたインターベンションには不可欠です。2024年6月、Journal of the Society for Cardiovascular Angiography &Interventionsに掲載された論文では、経大腿経カテーテル大動脈弁置換術（TAVR）の際の止血が、通常、縫合糸を介した血管閉鎖装置（VCD）を用いたプレクロージャー法で達成されることが論じられています。最近では、止血に失敗した場合にシース抜去後にコラーゲンプラグVCDを組み込むハイブリッドアプローチが導入されています。

世界の人口動態は、出生率の低下とヘルスケアの進歩による平均寿命の延長により、高齢化へと顕著にシフトしています。世界保健機関（WHO）によると、60歳以上の人口は2050年までに倍増し、世界で約21億人に達すると予想されています。この人口動態の変化は、高齢者における心血管疾患（CVD）を含む加齢関連疾患の有病率の増加を強調しています。米国心臓協会が2023年11月に発表した論文によると、心不全は広範かつ多面的な心血管系の疾患であり、670万人以上の米国人に影響を与え、特に65歳以上の高齢者の間で流行しています。心血管系疾患に罹患しやすい高齢化社会は、診断・治療手技の需要を促進し、市場成長を牽引しています。

医療機器の技術的進歩は、市場成長を促進する上で極めて重要です。材料、設計、機能の革新により、より効果的で信頼性の高い止血バルブが開発されています。例えば、先進的なポリマーやコーティングを使用することで、これらのデバイスの耐久性や生体適合性が向上し、血栓症や感染症などの合併症が減少しています。加えて、使いやすいロック機構や強化されたシーリング能力などの新しい機能を取り入れることで、臨床現場における止血バルブの効率が向上しています。例えば、ボストン・サイエンティフィック社のWATCHDOG止血バルブは、リークを最小限に抑える革新的なクロススリット設計を採用し、複数のデバイスを同時に収容できる8Fの内腔を備えています。さらに、手技中の快適性を高めるために設計されたサムレスト機能も備えています。これらの設計要素は総体的に、出血と空気塞栓症のリスク低減に貢献し、医療介入全体を通じて患者の安全を最優先しています。このような技術的改善により、手技がより安全で効率的になり、止血バルブの採用が促進されます。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 止血バルブ市場：変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • 止血バルブ市場：分析ツール
    • 業界分析：ポーターのファイブフォース分析
    • PESTEL分析
    • パイプライン分析

第4章 止血バルブ市場：種類別の推定と動向分析

  • 世界の止血バルブ市場：種類別のダッシュボード
  • 世界の止血バルブ市場：種類別の変動分析
  • 世界の止血バルブ市場：種類別 (収益ベース)
  • 止血バルブ用Y字コネクタ
  • ダブルY字コネクタ式止血バルブ
  • 片手操作式止血バルブ
  • その他

第5章 止血バルブ市場：用途別の推定と動向分析

  • 世界の止血バルブ市場：用途別のダッシュボード
  • 世界の止血バルブ市場：用途別の変動分析
  • 世界の止血バルブ市場：用途別 (収益ベース)
  • 血管造影検査
  • 血管形成術

第6章 止血バルブ市場：最終用別の推定と動向分析

  • 世界の止血バルブ市場：最終用途別のダッシュボード
  • 世界の止血バルブ市場：最終用途別の変動分析
  • 世界の止血バルブ市場：最終用途別 (収益ベース)
  • 病院
  • 外来手術センター
  • その他

第7章 止血バルブ市場：地域別の推定と動向分析 (国別、種類別、用途別、最終用途別)

  • 地域別ダッシュボード
  • 市場規模の予測と動向分析 (2018～2030年)
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 最新動向と影響分析：主要メーカー別
  • 企業/競合の分類
  • ベンダー情勢
    • 主要な流通業者・チャネルパートナーの一覧
    • 主要顧客
    • 主要企業の市場シェア分析 (2024年)
  • 企業プロファイル
    • Boston Scientific Corporation
    • Teleflex Incorporated
    • Merit Medical Systems
    • B. Braun SE
    • Terumo Corporation
    • Abbott
    • Argon Medical Devices
    • Freudenberg Medical
    • SCW Medicath Ltd
    • Lepu Medical Technology（Beijing）Co.,Ltd.
    • Nipro
    • DeRoyal Industries, Inc.
    • Antmed Corporation
    • Beijing Demax Medical Technology Co
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 3 Global hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global hemostasis valve market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America hemostasis valve market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe hemostasis valve market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 27 UK hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 30 France hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 31 France hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific hemostasis valve market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 52 China hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 53 China hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 58 India hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 59 India hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America hemostasis valve market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Africa hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 83 South Africa hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 88 UAE hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 89 UAE hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 92 Kuwait hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait hemostasis valve market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Hemostasis valve market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Hemostasis Valve Market: Type Outlook Key Takeaways
  • Fig. 15 Global Hemostasis Valve Market: Type Movement Analysis
  • Fig. 16 Global Hemostasis Valve Y- Connectors Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global Double Y- Connector Hemostasis Valves Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global One- Handed Hemostasis Valves Market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Hemostasis Valve Market: Application Outlook Key Takeaways
  • Fig. 21 Global Hemostasis Valve Market: Application Movement Analysis
  • Fig. 22 Global Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Angioplasty Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Hemostasis Valve Market: End Use Outlook Key Takeaways
  • Fig. 25 Global Hemostasis Valve Market: End Use Movement Analysis
  • Fig. 26 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional outlook, 2024 & 2030
  • Fig. 31 Global Hemostasis Valve Market: Region Movement Analysis
  • Fig. 32 North America Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia pacific Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 47 China Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 48 India Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 58 UAE Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 60 Strategy framework
目次
Product Code: GVR-4-68040-342-2

Hemostasis Valve Market Size & Trends:

The global hemostasis valve market size was estimated at USD 184.6 million in 2024 and is projected to grow at a CAGR of 5.8% from 2025 to 2030. The increasing prevalence of cardiovascular diseases, supportive regulatory frameworks, rising geriatric population, and technological advancements are significantly driving the market growth. The World Heart Report 2024 highlights that air pollution worsens all major cardiovascular diseases (CVDs). In 2019, nearly 70% of the 4.2 million deaths linked to ambient air pollution were due to cardiovascular issues, particularly ischaemic heart disease (1.9 million deaths) and stroke (900,000 deaths). This, in turn, drives the demand for diagnostic and therapeutic procedures like angiography and angioplasty, where hemostasis valves are essential to ensure patient safety by controlling blood flow during catheterization procedures.

The growing preference for minimally invasive procedures is another significant factor propelling the market growth. Minimally invasive techniques offer numerous benefits over traditional open surgeries, including reduced pain, shorter hospital stays, faster recovery times, and lower risk of complications. As a result, there is a heightened demand for medical devices that facilitate these procedures. Hemostasis valves are integral to minimally invasive catheter-based interventions, as they enable precise control of blood flow and prevent leakage during the procedure. In June 2024, an article in the Journal of the Society for Cardiovascular Angiography & Interventions discussed how hemostasis during transfemoral transcatheter aortic valve replacement (TAVR) is usually achieved with a suture-mediated vascular closure device (VCD) via a preclosure technique. Recently, a hybrid approach has been introduced, incorporating a collagen-plug VCD after sheath removal in cases where hemostasis fails.

The global demographic landscape is undergoing a notable shift towards aging, driven by declining birth rates and advancements in healthcare that have prolonged life expectancy. According to the World Health Organization (WHO), the number of people aged 60 years and older is expected to double by 2050, reaching approximately 2.1 billion globally. This demographic transition underscores the increasing prevalence of age-related conditions, including cardiovascular diseases (CVDs) among older adults. According to the article published by the American Heart Association in November 2023, heart failure is a widespread and multifaceted cardiovascular condition impacting more than 6.7 million Americans, particularly prevalent among individuals aged 65 and older. The aging population is susceptibility to cardiovascular diseases drive the demand for diagnostic and therapeutic procedures, driving the market growth.

Technological advancements in medical devices are pivotal in driving the market growth. Materials, design, and functionality innovations have developed more effective and reliable hemostasis valves. For instance, using advanced polymers and coatings has improved the durability and biocompatibility of these devices, reducing complications such as thrombosis and infection. In addition, incorporating novel features such as easy-to-use locking mechanisms and enhanced sealing capabilities has increased the efficiency of hemostasis valves in clinical settings. For instance, the WATCHDOG Hemostasis Valve by Boston Scientific Corporation incorporates an innovative cross-slit design to minimize leakage, complemented by an 8F inner lumen that simultaneously accommodates multiple devices. In addition, it includes a thumb rest feature designed for enhanced comfort during procedures. The design elements collectively contribute to reducing blood loss and the risk of air embolism, prioritizing patient safety throughout medical interventions. These technological improvements ensure that procedures are safer and more efficient, boosting the adoption of hemostasis valves.

Global Hemostasis Valve Market Report Segmentation

This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global hemostasis valve market report based on type, application, end-use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Hemostasis Valve Y- Connectors
  • Double Y- Connector Hemostasis Valves
  • One- Handed Hemostasis Valves
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Angiography
  • Angioplasty
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. Hemostasis Valve Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Growing demand for minimally invasive surgeries
      • 3.2.1.3. Improved healthcare infrastructure
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of hemostasis valves
      • 3.2.2.2. Regulatory hurdles
  • 3.3. Hemostasis Valve Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Hemostasis Valve Market: Type Estimates & Trend Analysis

  • 4.1. Global Hemostasis Valve Market: Type Dashboard
  • 4.2. Global Hemostasis Valve Market: Type Movement Analysis
  • 4.3. Global Hemostasis Valve Market by Type, Revenue
  • 4.4. Hemostasis Valve Y- Connectors
    • 4.4.1. Hemostasis valve Y- connectors market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Double Y- Connector Hemostasis Valves
    • 4.5.1. Double Y- connector hemostasis valves market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6. One- Handed Hemostasis Valves
    • 4.6.1. One - handed hemostasis valves market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Hemostasis Valve Market: Application Estimates & Trend Analysis

  • 5.1. Global Hemostasis Valve Market: Application Dashboard
  • 5.2. Global Hemostasis Valve Market: Application Movement Analysis
  • 5.3. Global Hemostasis Valve Market by Application, Revenue
  • 5.4. Angiography
    • 5.4.1. Angiography market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Angioplasty
    • 5.5.1. Angioplasty market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Hemostasis Valve Market: End Use Estimates & Trend Analysis

  • 6.1. Global Hemostasis Valve Market: End Use Dashboard
  • 6.2. Global Hemostasis Valve Market: End Use Movement Analysis
  • 6.3. Global Hemostasis Valve Market by End Use, Revenue
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Hemostasis Valve Market: Regional Estimates & Trend Analysis by Country, Type, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Boston Scientific Corporation
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Teleflex Incorporated
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Merit Medical Systems
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. B. Braun SE
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Terumo Corporation
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Abbott
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Argon Medical Devices
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Freudenberg Medical
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. SCW Medicath Ltd
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Lepu Medical Technology (Beijing)Co.,Ltd.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Nipro
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. DeRoyal Industries, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Antmed Corporation
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. Beijing Demax Medical Technology Co
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives